These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25563470)

  • 1. Analysis of the QRS morphology in lead V1 during 24-hour Holter electrocardiogram monitoring to evaluate function of a cardiac resynchronisation therapy device in patients with sinus rhythm: a pilot study.
    Pyszno-Prokopowicz D; Madej M; Baranowski R; Piotrowicz R
    Kardiol Pol; 2015; 73(6):404-10. PubMed ID: 25563470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R/S Ratio Variability in Lead V1 Observed between Selected Four 1-Minute ECG Fragments of 24-Hour ECG as a Predictor of Incomplete Resynchronization during Full 24-Hour ECG: Pilot Study.
    Pyszno-Prokopowicz D; Baranowski R; Bodalski R; Madej M; Piotrowicz R
    Ann Noninvasive Electrocardiol; 2016 Jul; 21(4):397-403. PubMed ID: 26514634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.
    Kamath GS; Cotiga D; Koneru JN; Arshad A; Pierce W; Aziz EF; Mandava A; Mittal S; Steinberg JS
    J Am Coll Cardiol; 2009 Mar; 53(12):1050-5. PubMed ID: 19298918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic correlates of mechanical dyssynchrony in recipients of cardiac resynchronization therapy devices.
    Behaghel A; Brunet-Bernard A; Oger E; Martins R; Donal E; Fournet M; Feneon D; Leclercq C; Mabo P; Daubert C
    Arch Cardiovasc Dis; 2015 Dec; 108(12):617-25. PubMed ID: 26498536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
    Peterson PN; Greiner MA; Qualls LG; Al-Khatib SM; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Hammill BG; Piccini JP; Hernandez AF; Curtis LH; Masoudi FA
    JAMA; 2013 Aug; 310(6):617-26. PubMed ID: 23942680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study.
    Hernández-Madrid A; Facchin D; Klepfer RN; Ghosh S; Matía R; Moreno J; Locatelli A
    Heart Rhythm; 2017 Apr; 14(4):541-547. PubMed ID: 28104482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronisation therapy in patients with atrioventricular nodal disease and reduced ejection fraction - can we afford it?
    Pathik B; Mathew T; Chahadi F; Sutton K; McGavigan AD
    Heart Lung Circ; 2015 Apr; 24(4):354-8. PubMed ID: 25488381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
    Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
    Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy.
    Urbanek B; Chudzik M; Klimczak A; Rosiak M; Lewek J; Wranicz JK
    Cardiol J; 2013; 20(4):411-7. PubMed ID: 23913460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel electrocardiographic predictor of clinical response to cardiac resynchronization therapy.
    Mollo R; Cosenza A; Coviello I; Stazi A; Russo G; Villano A; Sestito A; Bencardino G; Lanza GA; Crea F
    Europace; 2013 Nov; 15(11):1615-21. PubMed ID: 23794613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prominent R wave in ECG lead V1 predicts improvement of left ventricular ejection fraction after cardiac resynchronization therapy in patients with or without left bundle branch block.
    Bode WD; Bode MF; Gettes L; Jensen BC; Mounsey JP; Chung EH
    Heart Rhythm; 2015 Oct; 12(10):2141-7. PubMed ID: 26048194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of QRS duration and pacing location on pressure-volume loop evaluation of cardiac resynchronization therapy in end-stage heart failure.
    de Roest GJ; Allaart CP; de Haan S; Hendriks ML; Bronzwaer JG; van Rossum AC; de Cock CC
    Am J Cardiol; 2011 Dec; 108(11):1581-8. PubMed ID: 21890082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biventricular paced QRS predictors of left ventricular lead locations in relation to mortality in cardiac resynchronization therapy.
    Fontaine JM; Gupta A; Franklin SM; Kang CU; Whigham LA
    J Electrocardiol; 2015; 48(2):226-35. PubMed ID: 25552478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.